Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Lu AE58054 in Healthy Japanese and Caucasian Subjects

NCT01975779 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Cohort A1: Lu AE58054 or placebo
DRUG: Cohort A2: Lu AE58054 or placebo
DRUG: Cohort B1: Lu AE58054

Sponsor

H. Lundbeck A/S